Lohocla Research Corporation is a pioneering bioscience company based in Evanston, IL, dedicated to developing innovative therapeutics for chronic pain and addiction. With a multi-target approach, their groundbreaking medications aim to simultaneously modulate several neural systems associated with these conditions, offering superior efficacy and safety compared to single-target drugs.
Driven by a global mission, Lohocla is committed to bringing life-changing treatments to market, providing relief to millions of individuals suffering from un- or under-treated chronic pain and addiction worldwide. Through their cutting-edge research and development, Lohocla offers hope for a brighter future, where individuals can regain their quality of life and enjoy the company of loved ones once again.
Generated from the website